Xenetic Biosciences

Biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens.

HQ location

London, United Kingdom

Website

Launch date

2014

Employees

Market cap

Enterprise value

$313k

Share price

$3.92 XBIO

Company register number

https://twitter.com/xeneticbio https://www.facebook.com/xeneticbio https://www.linkedin.com/company/xenetic-biosciences-inc-/

Authorizing premium user...